Jefferies Group’s Pfizer PFE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q3 | $9.85M | Buy |
224,984
+70,327
| +45% | +$3.42M | 0.08% | 192 |
|
|
2022
Q2 | $8.11M | Buy |
154,657
+111,507
| +258% | +$5.68M | 0.07% | 238 |
|
|
2022
Q1 | $2.23M | Buy |
43,150
+43,144
| +719,067% | +$2.24M | 0.01% | 655 |
|
|
2021
Q4 | $354 | Sell |
6
-248,887
| -100% | -$12.3M | ﹤0.01% | 1586 |
|
|
2021
Q3 | $10.7M | Buy |
248,893
+45,549
| +22% | +$2.02M | 0.08% | 243 |
|
|
2021
Q2 | $7.96M | Sell |
203,344
-70,147
| -26% | -$2.73M | 0.05% | 326 |
|
|
2021
Q1 | $9.91M | Sell |
273,491
-221,137
| -45% | -$7.85M | 0.09% | 197 |
|
|
2020
Q4 | $18.2M | Buy |
494,628
+135,904
| +38% | +$4.98M | 0.14% | 118 |
|
|
2020
Q3 | $12.5M | Buy |
358,724
+230,381
| +180% | +$8.08M | 0.14% | 109 |
|
|
2020
Q2 | $3.98K | Sell |
128,343
-41,158
| -24% | -$1.4M | 0.05% | 331 |
|
|
2020
Q1 | $5.25M | Sell |
169,501
-60,176
| -26% | -$2.05M | 0.06% | 308 |
|
|
2019
Q4 | $8.54M | Buy |
229,677
+129,909
| +130% | +$4.63M | 0.07% | 283 |
|
|
2019
Q3 | $3.4M | Sell |
99,768
-46,696
| -32% | -$1.7M | 0.03% | 738 |
|
|
2019
Q2 | $6.02M | Buy |
146,464
+113,012
| +338% | +$4.49M | 0.04% | 388 |
|
|
2019
Q1 | $1.35M | Sell |
33,452
-222,435
| -87% | -$8.91M | 0.01% | 1112 |
|
|
2018
Q4 | $10.6M | Buy |
255,887
+188,360
| +279% | +$7.82M | 0.09% | 187 |
|
|
2018
Q3 | $2.82M | Buy |
67,527
+2,898
| +4% | +$112K | 0.02% | 814 |
|
|
2018
Q2 | $2.23M | Sell |
64,629
-82,928
| -56% | -$2.83M | 0.01% | 840 |
|
|
2018
Q1 | $4.97M | Sell |
147,557
-62,418
| -30% | -$2.15M | 0.03% | 472 |
|
|
2017
Q4 | $7.22M | Sell |
209,975
-505,340
| -71% | -$17.2M | 0.03% | 428 |
|
|
2017
Q3 | $24.2M | Buy |
715,315
+687,567
| +2,478% | +$22.1M | 0.16% | 96 |
|
|
2017
Q2 | $884K | Sell |
27,748
-164,884
| -86% | -$5.2M | 0.01% | 1360 |
|
|
2017
Q1 | $6.25M | Sell |
192,632
-393,805
| -67% | -$12.4M | 0.05% | 419 |
|
|
2016
Q4 | $18.1M | Sell |
586,437
-561,155
| -49% | -$17.1M | 0.1% | 184 |
|
|
2016
Q3 | $36.9M | Buy |
1,147,592
+595,518
| +108% | +$19.9M | 0.19% | 85 |
|
|
2016
Q2 | $18.4M | Sell |
552,074
-924,939
| -63% | -$29.5M | 0.08% | 139 |
|
|
2016
Q1 | $41.5M | Sell |
1,477,013
-369,773
| -20% | -$10.6M | 0.24% | 55 |
|
|
2015
Q4 | $56.6M | Buy |
1,846,786
+1,610,664
| +682% | +$50.7M | 0.32% | 54 |
|
|
2015
Q3 | $7.04M | Sell |
236,122
-58,078
| -20% | -$1.86M | 0.04% | 360 |
|
|
2015
Q2 | $9.36M | Buy |
294,200
+292,033
| +13,476% | +$9.52M | 0.05% | 312 |
|
|
2015
Q1 | $71K | Sell |
2,167
-397,179
| -99% | -$12.6M | ﹤0.01% | 1908 |
|
|
2014
Q4 | $11.8M | Buy |
399,346
+367,946
| +1,172% | +$10.6M | 0.07% | 239 |
|
|
2014
Q3 | $881K | Sell |
31,400
-376,384
| -92% | -$10.6M | 0.01% | 1058 |
|
|
2014
Q2 | $11.5M | Buy |
407,784
+383,932
| +1,610% | +$10.9M | 0.1% | 185 |
|
|
2014
Q1 | $727K | Sell |
23,852
-27,141
| -53% | -$809K | 0.01% | 1078 |
|
|
2013
Q4 | $1.48M | Buy |
50,993
+35,096
| +221% | +$1.02M | 0.01% | 676 |
|
|
2013
Q3 | $433K | Sell |
15,897
-833,926
| -98% | -$22.7M | ﹤0.01% | 1257 |
|
|
2013
Q2 | $22.6M | Buy |
+849,823
| New | +$23.5M | 0.24% | 57 |
|
Other funds holding PFE
Jefferies Group's PFE Position: Q3 2022 in Review
Jefferies Group increased its Pfizer (PFE) stake by 45% in Q3 2022, buying an estimated $3.42M and bringing the position to 224,984 shares worth $9.85M. The position accounts for 0.08% of the portfolio, ranked #192.
Jefferies Group first reported a position in PFE in Q2 2013 and has held it in 38 quarters since. The position peaked at $56.6M in Q4 2015. 3,085 funds tracked by Wall St. Rank hold PFE as of Q3 2022.
- Jefferies Group held 224,984 shares of Pfizer worth $9.85M as of Q3 2022.
- Jefferies Group bought 70,327 Pfizer shares in Q3 2022, an estimated $3.42M.
- Pfizer made up 0.08% of Jefferies Group's portfolio in Q3 2022, its #192 holding.
- Jefferies Group first reported a position in Pfizer in Q2 2013 and has held it in 38 quarters since.
- Jefferies Group's Pfizer position peaked at $56.6M in Q4 2015.
- 3,085 funds tracked by Wall St. Rank held Pfizer as of Q3 2022.
Based on Jefferies Group's 13F filing for Q3 2022, filed 14 Nov 2022.